{"Exaggerate": "The claim of \"complete remission\" of Crohn's disease is an exaggeration of the study's findings, which actually reported that only 5 out of 11 subjects in the cannabis group achieved complete remission.", "Lack enough support": "The claim lacks enough support as it is based on a single pilot clinical trial with a small sample size of 22 participants.", "Problematic assumption": "The claim assumes that the results of the single study can be generalized to all cases of Crohn's disease, which may not be accurate due to the limited sample size and specific conditions of the study.", "Exist alternative explanation": "The claim does not consider alternative explanations for the observed improvements in Crohn's disease symptoms, such as the potential placebo effect or other factors that may have contributed to the participants' remission.", "Contradict fact": "The claim contradicts the fact that Crohn's disease is an incurable condition, as stated by the expert's verdict. The study's findings only indicate a reduction in symptoms, not a complete cure.", "Understate": "The claim may understate the limitations and complexities of Crohn's disease treatment by suggesting that marijuana alone can lead to complete remission, without considering other medical interventions or lifestyle changes that are commonly recommended for managing the condition.", "Falters at times": "The claim falters by presenting the study's results without providing sufficient context or clarifying the specific criteria for defining \"complete remission\" in the context of Crohn's disease."}